Cargando…
Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality
We here report that alpha 1-acid glycoprotein, a typical acute phase protein, protects mice from lethal shock induced by tumor necrosis factor (TNF) or endotoxin. The protection is observed both in normal and in galactosamine-sensitized mice. Optimal desensitization requires at least 3 mg alpha 1-ac...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191695/ https://www.ncbi.nlm.nih.gov/pubmed/7931089 |
_version_ | 1782147065218859008 |
---|---|
collection | PubMed |
description | We here report that alpha 1-acid glycoprotein, a typical acute phase protein, protects mice from lethal shock induced by tumor necrosis factor (TNF) or endotoxin. The protection is observed both in normal and in galactosamine-sensitized mice. Optimal desensitization requires at least 3 mg alpha 1-acid glycoprotein administered 2 h before the lethal challenge. Under these conditions, complete inhibition of all TNF-induced metabolic changes was observed: fall in body temperature, release of liver transaminases, enhanced clotting time, and mortality. The known platelet aggregation-inhibitory activity of alpha 1-acid glycoprotein provides a possible explanation for this protective capacity. |
format | Text |
id | pubmed-2191695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1994 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21916952008-04-16 Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality J Exp Med Articles We here report that alpha 1-acid glycoprotein, a typical acute phase protein, protects mice from lethal shock induced by tumor necrosis factor (TNF) or endotoxin. The protection is observed both in normal and in galactosamine-sensitized mice. Optimal desensitization requires at least 3 mg alpha 1-acid glycoprotein administered 2 h before the lethal challenge. Under these conditions, complete inhibition of all TNF-induced metabolic changes was observed: fall in body temperature, release of liver transaminases, enhanced clotting time, and mortality. The known platelet aggregation-inhibitory activity of alpha 1-acid glycoprotein provides a possible explanation for this protective capacity. The Rockefeller University Press 1994-10-01 /pmc/articles/PMC2191695/ /pubmed/7931089 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality |
title | Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality |
title_full | Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality |
title_fullStr | Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality |
title_full_unstemmed | Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality |
title_short | Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality |
title_sort | protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191695/ https://www.ncbi.nlm.nih.gov/pubmed/7931089 |